Gene · 9780
Papers3,250
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,250
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Propeller with a Flexible Twist: A Computational Analysis of Intrinsically Disordered Regions in PIEZO Gating and PIEZO-Associated Channelopathies. | Proteomes | 2026 | 42647377 | PubTator, text mining | PubMed |
| Inflammation-Associated Changes in Piezo1 Expression, Mitophagy-Related Markers, and Matrix Dysregulation in an LPS-Stimulated Co-Culture Organoid System. | Cells | 2026 | 42645208 | PubTator, text mining | PubMed |
| Utero-placental calcium and magnesium ion channels: A systematic review of obstetric implications of their alterations. | Channels (Austin) | 2026 | 42644398 | PubTator, text mining | PubMed |
| Deciphering osteoarthritis cartilage heterogeneity: gene expression-guided patient stratification and microbiome correlations. | Front Microbiol | 2026 | 42639051 | PubTator, text mining | PubMed |
| The role of adipose tissue macrophages in adipose tissue fibrosis. | Metabolism | 2026 | 42636953 | PubTator, text mining | PubMed |
| Extracellular matrix stiffness and mechanotransduction in cancer drug resistance. | Drug Resist Updat | 2026 | 42632298 | PubTator, text mining | PubMed |
| The mechano-immunological barrier in fibrosis-associated lung cancer: targeting matrix stiffness and the Piezo1 axis for microenvironment normalization. | Front Pharmacol | 2026 | 42630570 | PubTator, text mining | PubMed |
| Mitochondrial dysfunction promotes keloid progression through metabolic reprogramming: A narrative review. | Tissue Cell | 2026 | 42628186 | PubTator, text mining | PubMed |
| Mechanotransduction and cell fate: from molecular sensors to multicellular self-organization. | Front Cell Dev Biol | 2026 | 42625795 | PubTator, text mining | PubMed |
| Piezo channels in physical field therapy: From mechanotransduction mechanisms to bioelectromagnetic modulation and biomedical applications. | Mechanobiol Med | 2026 | 42620582 | PubTator, text mining | PubMed |
| Piezo1 channel: structure, mechanogating mechanism, functions, diseases and therapeutic strategy. | Mol Biomed | 2026 | 42616243 | PubTator, text mining | PubMed |
| Decoding osteosarcoma mechanobiology: PIEZO channels in tumor progression, immune remodeling, and pain. | Cancer Metastasis Rev | 2026 | 42616189 | PubTator, text mining | PubMed |
| Endothelial PIEZO1 regulates Weibel-Palade body exocytosis. | Blood | 2026 | 42611778 | PubTator, text mining | PubMed |
| Spatial architecture of atherosclerotic plaques: coordinating immune responses through mechanotransduction and vesicular trafficking. | Front Cell Dev Biol | 2026 | 42609415 | PubTator, text mining | PubMed |
| The role of ECM-PIEZO1-axis-mediated mechanosensation in the central nervous system. | Front Neurol | 2026 | 42609405 | PubTator, text mining | PubMed |
| Physical activity and the Neuro-Immuno-Fascial interface in cancer patients: mechanisms, clinical evidence, and therapeutic integration. | Front Oncol | 2026 | 42602326 | PubTator, text mining | PubMed |
| Endothelial Calcium Dysregulation as an Early Trigger of Vascular Dysfunction: Insights into Heavy Metal Toxicity : Heavy Metals and Endothelial Ca2+ Dysregulation. | Handb Exp Pharmacol | 2026 | 42599297 | PubTator, text mining | PubMed |
| Noninvasive biophysical modulations of Piezo ion channels. | Microsyst Nanoeng | 2026 | 42595746 | PubTator, text mining | PubMed |
| Paravertebral extramedullary haematopoiesis revealing previously unrecognised hereditary xerocytosis. | BMJ Case Rep | 2026 | 42595386 | PubTator, text mining | PubMed |
| Piezo1 inhibition by Saikosaponin B1 alleviates mitochondrial damage and apoptosis in osteoarthritic chondrocytes. | Biochem Pharmacol | 2026 | 42595096 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9780/papers?page=4